Cervarix related Press Releases
New data for GlaxoSmithKline's vaccine, Cervarix, presented at IPV Conference
New data for GlaxoSmithKline's vaccine, Cervarix, presented at IPV Conference Issued: Friday 8 May 2009, London, UK & Malmö, Sweden Key results from three important studies of the cervical
... Read more...GlaxoSmithKline submits final study data to FDA for cervical cancer vaccine
Cervarix® U.S. regulatory update GlaxoSmithKline submits final study data to FDA for cervical cancer vaccine Issued: Monday 30th March 2009, Philadelphia US & London UK GlaxoSmithKline
... Read more...PRESS RELEASE: GSK submits Cervarix licence application to Japan’s health authorities
GSK submits Cervarix™ licence application to Japan’s health authorities For UK business and financial media (not for distribution to US media) Issued – 28 September 2007, London (UK) and... Read more...
PRESS RELEASE: GSK seeks prequalification for Cervarix from the World Health Organization
GSK seeks prequalification for Cervarix™ from the World Health Organization after obtaining marketing approval in Europe For business and financial press only Issued — Thursday 4 October 2007,... Read more...
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges




